Clinical trial
Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse
NCT00373503 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00373503 |
|---|---|
| Title | Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse |
| Official title | Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Marijuana Dependence |
| Intervention type | Drug |
| Interventions | Lofexidine, dronabinol, Marijuana |
| Enrollment | 8 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Sep 8, 2006 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: